Citius Oncology, Inc. (CTOR) KPIs and segments

CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$0.52−0.03 (-5.87%)

Close on Nov 12, 2026Market cap $48.56MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Citius Oncology's business

Coming soon

This tab will track the numbers specific to Citius Oncology's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?